Siemens Healthineers (OTCMKTS:SMMNY) Stock Rating Lowered by UBS Group

Siemens Healthineers (OTCMKTS:SMMNY) was downgraded by research analysts at UBS Group from a “strong-buy” rating to a “hold” rating in a report issued on Thursday, Zacks.com reports.

Separately, Sanford C. Bernstein upgraded shares of Siemens Healthineers to a “strong-buy” rating in a research note on Wednesday, July 31st.

Siemens Healthineers Stock Performance

OTCMKTS:SMMNY opened at $29.99 on Thursday. Siemens Healthineers has a 52 week low of $24.01 and a 52 week high of $31.73. The company has a fifty day simple moving average of $28.00 and a two-hundred day simple moving average of $28.68.

Siemens Healthineers (OTCMKTS:SMMNY) last released its earnings results on Wednesday, July 31st. The company reported $0.28 EPS for the quarter. The company had revenue of $5.84 billion for the quarter.

About Siemens Healthineers

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.